Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Viewpoint

  • 158 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • …
  • 14
  • 15
  • 16
  • Next →
Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better
Ayumi Usui-Ouchi, Martin Friedlander
Ayumi Usui-Ouchi, Martin Friedlander
View: Text | PDF

Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better

  • Text
  • PDF
Abstract

Authors

Ayumi Usui-Ouchi, Martin Friedlander

×

How to write a scientific masterpiece: an update for 2019
Ushma S. Neill
Ushma S. Neill
View: Text | PDF

How to write a scientific masterpiece: an update for 2019

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

Academia and industry: allocating credit for discovery and development of new therapies
Jeffrey S. Flier
Jeffrey S. Flier
View: Text | PDF

Academia and industry: allocating credit for discovery and development of new therapies

  • Text
  • PDF
Abstract

Authors

Jeffrey S. Flier

×

The physician-scientist: defending vaccines and combating antiscience
Peter Hotez
Peter Hotez
View: Text | PDF

The physician-scientist: defending vaccines and combating antiscience

  • Text
  • PDF
Abstract

Authors

Peter Hotez

×

Empowering ASCI’s support of physician-scientists through stronger institutional connections
Kieren A. Marr, W. Kimryn Rathmell, John B. Hawley, Karen D. Guth
Kieren A. Marr, W. Kimryn Rathmell, John B. Hawley, Karen D. Guth
View: Text | PDF

Empowering ASCI’s support of physician-scientists through stronger institutional connections

  • Text
  • PDF
Abstract

The American Society for Clinical Investigation (ASCI), a nonprofit honorary society, was established to support physician-scientists by serving as a benchmark of excellence in medical research, a forum to celebrate advances in medicine, and a vehicle to communicate advances that bridge basic and translational research and their implementation across the growing myriad of medical specialties. A core intention of the Society is to engage the medical research community broadly through transparent communications of our activities and initiatives with the institutions that comprise the base for our membership. Recognizing the importance in identifying and actuating a strategy to support the Society’s broad mission, the current leadership has undertaken a strategic plan that initiates with the goal of revamping its Institutional Representatives program. While the Society has grown with the historical privilege of close connections to institutions through an informal web created largely by the elected membership, we aim to improve institutional engagement towards overall goals of embracing and enhancing diversity of our community and implementing future collaborative programs to support physician-scientists. We briefly review ASCI’s history, mission, and structure, and present the blueprint of the new Institutional Representatives program.

Authors

Kieren A. Marr, W. Kimryn Rathmell, John B. Hawley, Karen D. Guth

×

The JCI Scholar experience: perspectives from young physician-scientists
Austin K. Mattox, Justin Lowenthal
Austin K. Mattox, Justin Lowenthal
View: Text | PDF

The JCI Scholar experience: perspectives from young physician-scientists

  • Text
  • PDF
Abstract

Authors

Austin K. Mattox, Justin Lowenthal

×

Precision medicine: discovering clinically relevant and mechanistically anchored disease subgroups at scale
Antony Rosen, Scott L. Zeger
Antony Rosen, Scott L. Zeger
View: Text | PDF

Precision medicine: discovering clinically relevant and mechanistically anchored disease subgroups at scale

  • Text
  • PDF
Abstract

Authors

Antony Rosen, Scott L. Zeger

×

Promises, promises, and precision medicine
Michael J. Joyner, Nigel Paneth
Michael J. Joyner, Nigel Paneth
View: Text | PDF

Promises, promises, and precision medicine

  • Text
  • PDF
Abstract

Authors

Michael J. Joyner, Nigel Paneth

×

Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies
Mark W. Dewhirst, Yvonne M. Mowery, James B. Mitchell, Murali K. Cherukuri, Timothy W. Secomb
Mark W. Dewhirst, Yvonne M. Mowery, James B. Mitchell, Murali K. Cherukuri, Timothy W. Secomb
View: Text | PDF

Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies

  • Text
  • PDF
Abstract

Authors

Mark W. Dewhirst, Yvonne M. Mowery, James B. Mitchell, Murali K. Cherukuri, Timothy W. Secomb

×

Immunotherapy transforms cancer treatment
Neeha Zaidi, Elizabeth M. Jaffee
Neeha Zaidi, Elizabeth M. Jaffee
View: Text | PDF

Immunotherapy transforms cancer treatment

  • Text
  • PDF
Abstract

Authors

Neeha Zaidi, Elizabeth M. Jaffee

×
  • ← Previous
  • 1
  • 2
  • …
  • 14
  • 15
  • 16
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts